Who We Are?

Compsit3 is an early-stage molecular imaging company focused on the development and commercialization of molecular imaging probes for the non-invasive detection of tissue inflammation. Our lead technology is a probe for detecting tissue C3d, a robust marker of immune activation. C3d-imaging is better and safer than a tissue biopsy for the assessment of disease activity and therapeutic response to complement inhibitors and other immune modulators, and it will help clinicians to personalize each patient’s treatment. This will improve treatment, while also avoiding unnecessary drug side effects and additional biopsy procedures.